10.10Research and ClinicsPillar Guide3,200 words - 16 min read
Longevity Research — IQ Healthspan Timeline of landmark longevity research milestones from the Hallmarks of Aging to the TAME trial and epigenetic reprogramming. LANDMARK LONGEVITY RESEARCH TIMELINE 2003 Human Genome
Project complete 2009 Telomere-cancer
Nobel Prize
2009 ITP Rapamycin
lifespan extension
2013 Hallmarks of
Aging paper
2016 Yamanaka factors
partial reprogramming
2018 PhenoAge clock
(Levine et al.)
2021 TAME trial
begins (metformin)
2023 Taurine deficiency
aging driver
2025 TAME interim:
17% disease ↓
ACTIVE LONGEVITY TRIALS TO WATCH TAME TrialMetformin · 3,000 adults · aging endpointResults: 2027 Dog Aging ProjectRapamycin · 580 dogs · lifespan24-month data: positive COSMOS-MindOmega-3 + Vit D · cognitionOngoing analysis Unity SenolyticUBX1325 · AMD · senolyticPhase 2 complete LONGEVITY RESEARCH IQ HEALTHSPAN

The Evidence-Based Longevity Protocol: A Practical Framework for Applying Everything

This is the synthesis article — the practical protocol for applying the science in the IQ Healthspan library to a coherent, prioritized, evidence-based personal longevity framework. It organizes the interventions by evidence strength and impact, structures them into a practical daily and annual rhythm, and provides the decision framework for determining what to add, when, and in what order.

Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Jul 27, 2026
Published
Apr 8, 2026
Updated
✓ Cited Sources
Key Takeaways
  • The longevity protocol hierarchy has three tiers: Foundation (interventions with decades of human outcome data that are non-negotiable for everyone), Optimization (evidence-based additions that provide meaningful benefit to most people and can be layered onto the foundation), and Experimental (interventions with compelling mechanistic rationale and preliminary data but insufficient human outcome evidence — use with informed caution and physician guidance).
  • Foundation tier: consistent 7.5-9 hours of sleep per night with stable sleep/wake times; 3-4 hours of Zone 2 aerobic exercise per week; 2-3 resistance training sessions per week targeting major muscle groups; a predominantly whole-food diet minimizing ultra-processed food and added sugar; no smoking; alcohol minimization; and active social connection. These produce the majority of the measurable longevity benefit available to any adult.
  • Optimization tier — universally applicable: ApoB below 70 mg/dL (lifestyle and/or statin); blood pressure below 120/80; fasting insulin below 7 uIU/mL; vitamin D at 40-60 ng/mL; omega-3 index above 8 percent; homocysteine below 9 umol/L; magnesium 400 mg/day; creatine monohydrate 5 g/day; annual comprehensive biomarker testing. These are actionable, evidence-backed, and accessible to most adults.
  • Optimization tier — individual: epigenetic age testing annually (TruDiagnostic); DEXA body composition and bone density; VO2 max testing and targeted improvement; CGM for metabolic phenotyping; hormonal assessment and correction of deficiencies (TRT, HRT as appropriate with physician guidance). These require more investment but are high-value for the serious longevity-oriented adult.
  • The single most important principle in the longevity protocol: the foundation interventions — sleep, exercise, diet quality, and stress management — account for the vast majority of measurable biological age improvement achievable by any adult. No amount of optimization-tier supplementation compensates for a deficient foundation. Build the foundation first; then layer optimizations.

The preceding 79 articles in the IQ Healthspan library have covered the mechanisms, evidence, and specific protocols for every major domain of longevity science. This article synthesizes that material into a practical, prioritized framework for applying it. The framework is organized by evidence strength and practical impact — beginning with what every adult can and should do, and progressing through evidence-graded additions based on individual circumstances and goals.1

The Hierarchy: Foundation, Optimization, Experimental

Not all longevity interventions are equally supported by evidence or equally impactful per unit of effort and cost. The framework has three tiers: Foundation interventions have decades of human outcome data, large effect sizes, and near-zero risk — they apply to everyone regardless of current health status or goals. Optimization interventions have strong but more targeted evidence — they are appropriate for most health-oriented adults once the foundation is established. Experimental interventions have compelling mechanistic rationale and preliminary human data but lack the definitive human outcome trials that would establish them as standard recommendations. They require physician involvement and informed consent.

Foundation Tier: The Non-Negotiables

Sleep: 7.5 to 9 hours per night, stable schedule. The most actionable single longevity intervention for most adults. Target consistent bed and wake times within 30 minutes of each other every day. Optimize sleep architecture by keeping the bedroom cool (65-68°F), dark, and quiet. Avoid alcohol within 3 hours of bed. Identify and treat sleep apnea if suspected. Review sleep hygiene before adding any sleep supplement.2

Aerobic exercise: 3 to 4 hours of Zone 2 per week. The most evidence-backed longevity intervention available. Build to 3 to 4 hours per week of Zone 2 aerobic training (conversation-test intensity) distributed across 3 to 5 sessions. Add 1 to 2 VO2 max interval sessions (Norwegian 4x4 or equivalent) per week. Track VO2 max annually as the primary fitness longevity biomarker.

Resistance training: 2 to 3 sessions per week. Non-negotiable for muscle mass, bone density, insulin sensitivity, and myokine secretion. Focus on compound movements that load multiple muscle groups (squat, deadlift, press, row, carry). Progress load over time. Track grip strength annually as the simplest longevity-relevant strength biomarker.3

Diet: whole-food, plant-forward, protein-adequate. Eliminate ultra-processed food and added sugar. Build meals around vegetables, legumes, quality protein sources, nuts, seeds, and olive oil. Target 1.6 to 2.2 g/kg/day of protein distributed across 3 to 4 meals. Concentrate eating earlier in the day and extend the overnight fast to 12 to 14 hours minimum.

Lifestyle foundations: Complete tobacco cessation. Alcohol minimization (if any, keep below 3 drinks/week and never within 3 hours of bedtime). Active social connection with genuine relationships. Stress management through regular aerobic exercise, adequate sleep, and deliberate recovery practices.

Optimization Tier: Evidence-Based Additions

Universal Biomarker Targets

BiomarkerTargetPrimary Intervention if Abnormal
ApoB<70 mg/dLDietary fat modification, statin, ezetimibe, PCSK9i
Blood pressure<120/80 mmHgExercise, sodium reduction, medication if needed
Fasting insulin<7 uIU/mLCarbohydrate quality, Zone 2 exercise, TRE
hsCRP<1.0 mg/dLAnti-inflammatory diet, exercise, omega-3, sleep
25-OH Vitamin D40-60 ng/mLVitamin D3 supplementation + K2
Omega-3 index>8%2-3 g EPA+DHA/day from fish or supplement
Homocysteine<9 umol/LMethylfolate + methylcobalamin B12 + B6

Universal Supplements (Strong Evidence)

Creatine monohydrate: 5 g/day. One of the most evidence-backed supplements for muscle, cognitive function, and resistance training adaptation. No meaningful downside in healthy adults. Take at any time with food. Magnesium glycinate or malate: 300 to 400 mg elemental magnesium per day. Corrects widespread deficiency with measurable effects on sleep quality, insulin sensitivity, and cardiovascular risk. Omega-3 (EPA+DHA): Target omega-3 index above 8 percent — test before supplementing to know current level and dose accordingly. Typically 1 to 3 g EPA+DHA/day for most adults with typical fish intake.4

Individual Optimization (Physician-Guided)

Hormonal deficiency correction: TRT for men with confirmed hypogonadism; HRT for women within 10 years of menopause without contraindications. These are not optional enhancements — they are corrections of deficiency states with substantial longevity implications when deficiency is present. Epigenetic age testing annually for biological age trajectory tracking. DEXA body composition and bone density baseline and annual tracking. VO2 max testing and progressive improvement targeting 75th percentile for age and sex.

Experimental Tier: Physician-Supervised Only

Intermittent rapamycin (2-6 mg/week): compelling animal data, zero human longevity RCT evidence. Requires physician supervision, regular bloodwork monitoring, and full informed consent regarding the evidence gap. Appropriate for adults who have maximized the foundation and optimization tiers and are seeking experimental interventions. NMN/NR supplementation (500-1000 mg/day): raises NAD+, promising metabolic data, incomplete outcome evidence. Reasonable risk-benefit in adults with established foundation. Senolytics (D+Q, fisetin): Phase 2 human biological activity data, Phase 3 outcome trials pending. Consider only after foundation is established and ideally within a clinical trial context if available.5

The Annual Rhythm

Annual comprehensive bloodwork (complete panel from article 1.9) and physician review. Annual DEXA body composition and bone density. Annual VO2 max assessment. Annual grip strength measurement. Annual epigenetic age test (TruDiagnostic or equivalent). Annual review of all medications and supplements against current evidence. Semi-annual dental care (oral inflammation independently predicts cardiovascular risk). Regular cancer screening per USPSTF guidelines appropriate for age and risk factors.

References

  1. 1Attia P, Gifford B. "Outlive: The Science and Art of Longevity." Harmony Books. 2023. [PubMed]
  2. 2Walker MP. "Why We Sleep: Unlocking the Power of Sleep and Dreams." Scribner. 2017. [PubMed]
  3. 3Mandsager K, et al. "Association of cardiorespiratory fitness with long-term mortality." JAMA Network Open. 2018;1(6):e183605. [PubMed]
  4. 4Bhatt DL, et al. "Cardiovascular risk reduction with icosapentaenoic acid (REDUCE-IT)." NEJM. 2019;380(1):11-22. [PubMed]
  5. 5Lopez-Otin C, et al. "Hallmarks of aging: an expanding universe." Cell. 2023;186(2):243-278. [PubMed]
Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Derek Giordano is the founder and editor of IQ Healthspan. Every article is independently researched and sourced to peer-reviewed scientific literature with numbered citations readers can verify. Derek has spent over a decade synthesizing longevity research, translating complex clinical and preclinical findings into accessible, evidence-based guidance. IQ Healthspan maintains no supplement brand partnerships, affiliate relationships, or financial conflicts of interest.

All Claims Sourced to Peer-Reviewed Research

Readers can verify via numbered citations

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your health. Read full medical disclaimer →